S1RA

4-(2-{[5-Methyl-1-(2-naphthyl)-1H-pyrazol-3-yl]oxy}ethyl)morpholin

4-(2-{[5-Methyl-1-(2-naphthyl)-1H-pyrazol-3-yl]oxy}ethyl)morpholine

4-(2-{[5-Méthyl-1-(2-naphtyl)-1H-pyrazol-3-yl]oxy}éthyl)morpholine

4-(2-{[5-METHYL-1-(NAPHTHALEN-2-YL)-1H-PYRAZOL-3-YL]OXY}ETHYL)MORPHOLINE

4-(2-{[5-METHYL-1-(NAPHTHALEN-2-YL)PYRAZOL-3-YL]OXY}ETHYL)MORPHOLINE

4-[2-[[5-Methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine

878141-96-9

Morpholine, 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]-

S1RA

ZW18DSD1H4

389-31-1

4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine

4-[2-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine

4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]-morpholine

4-​[2-​[[5-​methyl-​1-​(2-​naphthalenyl)​-​1H-​pyrazol-​3-​yl]​oxy]​ethyl]​-morpholine

A0A090N8Q0_HUMAN

E-52862;E52862;E 52862

KCNH2_HUMAN

MFCD25976945

OPRM_HUMAN

SGMR1_CAVPO

SGMR1_HUMAN

SGMR2_HUMAN

SGMR2_RAT

Sigma intracellular receptor 2

μ-type opioid receptor